Introduction
============

Hyperthyroidism is a common condition with a lifetime risk of 2--10% ([@bib1], [@bib2]). Graves' disease (GD) and toxic nodular goitre (TNG) are the most frequent causes of hyperthyroidism ([@bib2]). GD is an organ specific autoimmune disease, which causes hyperthyroidism due to the presence of autoantibodies, which stimulate thyroid follicular cells by binding to the TSH receptor ([@bib1]). In TNG, hyperthyroidism is the result of autonomous thyroid nodules, which produce thyroid hormones independent of TSH level ([@bib3]). Irrespective of its cause, hyperthyroidism is a multifactorial condition, which develops as a result of a complicated and currently not fully understood interplay between genetic and environmental factors ([@bib4], [@bib5], [@bib6], [@bib7]). Iodine intake, alcohol and smoking habits are some of the environmental factors influencing the prevalence of hyperthyroidism ([@bib5], [@bib8], [@bib9], [@bib10]). For several years, bacterial and/or viral infections have been suggested as biologically plausible environmental triggers in a number of autoimmune diseases, including GD ([@bib11], [@bib12]). Infections have been suggested to induce thyroid immunity by various mechanisms such as mimicking self-antigens, superantigen T-cell activation and inducing expression of human leucocyte antigens ([@bib13]). In line with that, we have previously suggested that infection with *Yersinia enterocolitica* may increase the risk of GD ([@bib13]). As the exposure to infections often follows a seasonal pattern, the observations of seasonal variations in month of birth among patients with autoimmune hypothyroidism ([@bib14]), diabetes type 1 ([@bib15]), multiple sclerosis and schizophrenia ([@bib16], [@bib17]) compared to the background population, further supports this hypothesis.

To our knowledge, the impact of month of birth for the development of GD has only received little attention ([@bib18], [@bib19]). Due to low power, the findings have been inconclusive. In contrast to GD, it has never been investigated whether TNG is influenced by seasonality in month of birth. However, seasonality in the time of diagnosis has been observed in patients with hyperthyroidism overall, and generally been attributed to variations in iodine intake and/or climatic factors ([@bib20]).

In a register-based nationwide cohort study, we evaluated whether season of birth influences the risk of hyperthyroidism due to either GD or TNG.

Materials and methods
=====================

Data sources
------------

Information regarding date of birth and death, vital status and demographics in the study population was obtained from The Danish Civil Registration System and The Danish Demographic Database (DDB) ([@bib21]).

Information regarding thyroid status was obtained from The Danish National Patient Registry (DNPR) or The Danish National Prescription Registry (DNPrR) ([@bib21]). DNPR covers, on an individual level, information on all hospital admissions since 1977 as well as outpatient visits since 1995. Diagnoses are coded according to The International Classification of Diseases (ICD) ([@bib21]). In DNPrR all information on drug prescriptions dispensed from Danish pharmacies has been registered according to the Anatomical Therapeutic Chemical (ATC) classification system since 1995. The register holds information on date of dispensing, ATC code, strength and quantity (defined daily doses) ([@bib21]).

Hyperthyroidism
---------------

A subject was classified as a case if he/she had an ICD-10 code for hyperthyroidism in DNPR in the period from January 1st 1995 through 31st of December 2012. GD was defined by the ICD-10 code E05.0 and TNG by the ICD-10 codes E05.1 or E05.2. Only individuals older than 18 years at diagnosis were included. Furthermore, in order only to include incident cases, the first 6 months of 1995 were used as a washout period.

In total, 56,624 subjects with a diagnosis of hyperthyroidism, of whom 36,087 had GD and 20,537 had TNG, were included in our study ([Fig. 1](#fig1){ref-type="fig"}).Figure 1Flowchart showing the selection of cases with Graves´ disease (GD) and toxic nodular goitre (TNG).

A control was eligible for inclusion if he or she (1) did not have a diagnosis of hyperthyroidism at the time of the diagnosis in the corresponding case and (2) had no registration of ever receiving antithyroid medication (ATC = H03B) in DNPrR.

Following the principles of density sampling, each case was age and sex matched with four control individuals from the background population ([@bib22]).

Data analysis
-------------

Statistical analyses were conducted using STATA version 13.0 (2013; Stata Corporation).

The association between GD or TNG and the risk of being born during a certain month of the year was evaluated by Cox regression. Age was chosen as the underlying time variable. To estimate differences in with-in year fluctuations across a 12-month period, the Walter--Elwood test for seasonality was used.

Likelihood ratio test (LR test) was used to test the significance of the Cox regression. The seasons were defined as winter (December, January and February), spring (March, April and May), summer (June, July and August) and autumn (September, October and November). December and winter was used as the reference for month and season, respectively. The exposure was month or season of birth and the outcome was either GD or TNG.

Significant differences were defined as a *P* value below 0.05, using two-tailed tests.

Results
=======

Selection and characteristics of the study population
-----------------------------------------------------

The ascertainment of the study population is visualised in the flowchart ([Fig. 1](#fig1){ref-type="fig"}). The mean age at diagnosis of GD and TNG was 55.7 and 64.0 years, respectively. As expected, the majority of GD cases (81.3 %) as well as TNG cases (83.8%) were women ([Table 1](#tbl1){ref-type="table"}). Table 1Demographic characteristics of the study population.PopulationGD^1^ControlsNumber (*n*)36,087144,348Females (%)29,321 (81.3)117,355 (81.3)Males (%)6766 (18.7)26,271 (18.2)**PopulationTNG2Controls**Number (*n*)20,53782,148Females (%)17,202 (83.8)68,002 (83.8)Males (%)3335 (16.2)13,307 (16.2)[^1]

Impact of month or season of birth for development of GD or TNG
---------------------------------------------------------------

The overall results are summarised in [Fig. 2](#fig2){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}. Neither for GD nor for TNG could we demonstrate a significant difference in birth rate across months or seasons of the year (Walter--Elwood test; X^2^ = 5.92 and X^2^ = 1.27, *P* = 0.052 and *P* = 0.53, respectively). Changing the reference month from December to any other month had no significant influence on the results of the Cox regression analyses (data not shown). Stratification for being born before 1960 or in 1960 or later showed a significant difference in the Walter--Elwood test in individuals born before 1960 and diagnosed with GD (*P* = 0.008) but not for those with TNG (*P* = 0.785). For individuals born 1960 or later, there was no significant difference in the Walter--Elwood test, whether in GD (*P* = 0.540) or in TNG (*P* = 0.235). The LR test for the Cox regression analyses was not significant. Stratification for sex showed significant difference in the Walter--Elwood test in men, both for GD (*P* = 0.001) and for TNG (*P* = 0.024). This was neither seen in women with GD (*P* = 0.14) nor with TNG (*P* = 0.31). Also in these analyses the LR-test was insignificant (*P* = 0.72).Figure 2Distribution of month of birth among cases with Graves´ disease (A) and toxic nodular goitre (B), respectively, and controls. Walter--Elwood test, *P* value = 0.052 and 0.53 for Graves´ disease and toxic nodular goitre, respectively. Table 2Cox regression of the association between month and season of birth and risk of Graves´ disease and toxic nodular goitre, respectively, as compared to controls.Month/seasonHazard ratio, 95% CI^5^**GD3TNG4**January^1^1.00 (0.95--1.05)0.90 (0.91--1.05)February^1^0.99 (0.94--1.05)0.99 (0.92--1.06)March^1^1.02 (0.97--1.08)1.01 (0.95--1.08)April^1^1.02 (0.47--1.07)1.00 (0.93--1.06)May^1^1.00 (0.95--1.05)1.00 (0.93--1.07)June^1^1.03 (0.97--1.07)1.05 (0.98--1.12)July^1^1.04 (0.99--1.09)1.02 (0.90--1.1)August^1^1.00 (0.96--1.06)0.99 (0.93--1.06)September^1^1.04(0.99--1.04)1.01 (0.95--1.08)October^1^0.99 (0.94--1.04)1.02 (0.95--1.09)November^1^0.95 (0.90--1.00)1.04 (0.97--1.11)Spring^2^−0.002 (−0.031--0.026)1.01 (0.98--1.05)Summer^2^0.004 (−0.02--0.038)1.03 (0.99--1.08)Autumn^2^−0.017 (−0.047--0.012)1.03 (0.99--1.08)[^2]

Discussion
==========

Utilising population-based nationwide Danish registers, and based on more than 56,000 patients with hyperthyroidism, we found no statistically significant association between the month or season of birth and the risk of developing GD or TNG later in life. The overall interpretation was not significantly influenced by stratification for gender or being born before or after 1960. In other words, irrespective of its cause, our findings do not support the hypothesis that season of birth is related to the development of hyperthyroidism. In this way another negative finding in the aetiology of hyperthyroidism has been added to that of our previous findings of lack of influence of a number of birth characteristics, such as birth weight, birth length, birth order and prematurity ([@bib23]).

To our knowledge, the association between month or season of birth and risk of GD has been evaluated in two previous studies, while this has never been studied in TNG. Hamilton*et al.* ([@bib19]) investigated the association between month or season of birth and subsequent risk of autoimmune thyroid disease. Based on nearly 3800 GD patients from three different study populations, the authors concluded that no consistent month of birth effects were detected in GD. In contrast, a study from Greece showed a peak in developing GD for males born during the winter and for females born in the spring and the autumn ([@bib18]). However, the latter study was quite small as it was based on only 359 GD patients ascertained from a single centre. In addition, the distribution of birth months of the cases was compared with the national and not the regional distribution which could influence their findings. Recently, based on the same methodology and design as the present study, we found a significantly increased risk of developing autoimmune hypothyroidism when born in the summer season, especially June ([@bib14]). Interestingly, in line with our results, Hamilton*et al.* found that variation in month of birth was related to a subsequent diagnosis of autoimmune hypothyroidism but not to GD ([@bib19]). Neither we nor others have obvious explanations for the discrepancy in seasonal variation in birth between these two phenotypes, and the databases used here do not contain information on genetics or the huge number of environmental variables which, at a multitude of levels interact and could give insight into this conundrum.

The fact that we found no significant association with either GD or TNG does not violate the hypothesis that season of birth influences other autoimmune diseases. Studies indicate that Epstein--Barr virus infection during the winter is associated with multiple sclerosis, and rotavirus infections during the winter stimulate the development of diabetes type I ([@bib17]). In contrast, Crohn's disease does not have significant seasonal variation ([@bib24]). A plausible explanation for these differences could be disease-specific interactions between susceptibility genes and environmental factors ([@bib25]).

All autoimmune diseases are probably caused by a combination of innate and adaptive immune regulatory abnormalities, but most probably not in the same way. Autoimmune conditions are more or less disease specific with different immune responses.

A clear strength of the present study is the inclusion of a large cohort from the entire Danish population selected from robust and validated registers. Other advantages are the relatively long follow-up period, clear case definitions and very few individuals lost to follow-up due to the register-based setting.

Despite this, our results should be interpreted in the light of possible limitations. The data were gathered from various registers, which are all based on the civil registration (CPR) numbers. These identifiers were not restricted to Danish born, but only to Danish-resident individuals. Accordingly, immigrants have been included without taking environmental and genetic confounding factors into consideration. However, based on information from Statistics Denmark ([www.dst.dk](http://www.dst.dk)), around 90% of the Danish population is Caucasian. Therefore, this limitation is unlikely to have had major impact on our results. Also the lack of clinical and biochemical data, including determination of TSH receptor antibodies or morphologic evaluation by thyroid scintigraphy or ultrasound, allowing even better subclassification, are limitations but no such data are available in the registers. When this is said, DNPR has been validated with respect to accuracy of hyperthyroidism and misclassification occurs in less than 2% of cases ([@bib26]). Since autoimmune diseases are associated, another limitation could be the lack of considering whether patients with GD had additional autoimmune diseases with month of birth variation ([@bib27]). Finally, lack of information on other environmental triggers such as smoking and alcohol intake, long known to affect aetiology of thyroid diseases, might have influenced the results because the consumption varies considerably among individuals ([@bib9], [@bib10], [@bib28]).

In conclusion, the present study, incorporating the entire Danish population, disclosed no significant association between month or season of birth and the subsequent diagnosis of GD or TNG.
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[^1]: ^1^Graves´ disease. ^2^Toxic nodular goitre.
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